CAS No. |
2098225-93-3 |
|---|---|
英文名称 |
- |
别名 |
Budigalimab;Research Grade Budigalimab (DHH02210);Research Grade Budigalimab;Budigalimab (anti-PD-1) |
用途 |
Budigalimab is a human IgG1 monoclonal antibody targeting the programmed cell death protein 1 (PD-1) receptor, designed for immunotherapy applications, particularly in the treatment of cancers by enhancing anti-tumor immune responses. |
|
|
评论 |
|---|